is taking a glp 1 safe GLP-1 Medications: Everything You Need to Know The GLP-1 revolution: What UAB

Combination therapy reduced glycated haemoglobin (HbA1c) by a mean of 0.44% more than other therapies and significantly improved the likelihood of achieving an HbA1c of 7.0% or lower, with a relative risk (RR) of 1.92

They've become essential tools in managing diabetes and now obesity, but their benefits extend even further

J., Sexton, P

The goal of the study was to ascertain whether GI adverse events (GI AEs), such as nausea/vomiting, diarrhea, constipation, and dyspepsia (indigestion), during the dose escalation phase (baseline to week 12) and from baseline to the end of treatment, are responsible for the greater weight loss seen with semaglutide compared to other GLP-1RAs

COTA: cotadutida

[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Zheng X, Xu F, Liang H, Cao H, Cai M, Xu W, et al